Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting tissue samples from patients with cancer undergoing radiation therapy. Healthy participants will also be allowed on the trial so their samples can be used in comparison to patients with malignancy

Detailed Description
-----------------
OBJECTIVES: Primary To maintain and create a University of Texas Southwestern Medical Center (UTSW) Radiation Oncology Tissue Resource and Registry/Database that will be used to explore genetic variations contributing to clinical outcomes through tissue analysis and outcome correlation. Tissue will be stored by the UTSTR and the database managed by Radiation Oncology. Secondary To document disease outcome (local recurrence, distant metastasis, overall survival) by treatment regimen and disease site. To document toxicity by treatment regimen and disease site. To establish a prospective registry/database consisting of patient demographics and outcomes to be used for future research. OUTLINE: Tissue, including surgical waste, venous blood/serum, urine, bone marrow, and other body fluids, may be collected (at planned surgery and routine medical visits) and preserved for future research. Demographic and disease and treatment information is obtained from patients (by interview or questionnaire), from medical records, and from national datasets. Patients may also be asked to provide additional blood samples and/or a small skin-punch biopsy sample. Patients are followed up every 6 months for the first two years following treatment and then yearly thereafter.

Official Title
-----------------
Tissue Procurement and Outcome Collection for Radiotherapy Treated Patients and Healthy Participants

Conditions
-----------------
Unspecified Adult Solid Tumor, Protocol Specific

Intervention / Treatment
-----------------
* Other: biologic sample preservation procedure
* Other: medical chart review
* Other: questionnaire administration


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Pathologically-proven diagnosis of malignancy Planning treatment with radiation therapy PATIENT CHARACTERISTICS: Able to perform follow-up visits Is a patient of the University of Texas Southwestern Medical Center physicians PRIOR CONCURRENT THERAPY: See Disease Characteristics Participation in other clinical trials is allowed Other prior or concurrent therapy for cancer, such as surgery and/or chemotherapy, is allowed. Criteria for eligibility: Able to provide written informed consent Age greater than 18 years old Males and Females are eligible Any ethnicity is eligible Criteria for ineligibility: -Patients not available for follow-up/future contact

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: biologic sample preservation procedure|nan|
|Other: medical chart review|nan|
|Other: questionnaire administration|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Maintenance a Tissue Resource and Registry/Database | Maintenance and creation of a University of Texas Southwestern Medical Center (UTSW) Radiation Oncology Tissue Resource and Registry/Database | 10 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Local recurrence | To document local recurrence by treatment regimen and disease site. | 5 years | 
| Distant metastasis | To document distant metastasis by treatment regimen and disease site. | 5 years | 
| Overall survival | To document overall survival by treatment regimen and disease site. | 5 years | 
| Toxicity by treatment regimen | To document toxicity by treatment regimen and disease site. | 1 year | 
| Establishment of a prospective registry/database | To establish a prospective registry/database consisting of patient demographics and outcomes to be used for future research. | 10 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
unspecified adult solid tumor, protocol specific